Background. Current theories favour multiple agent-speci®c neuronal actions for both general anaesthetics and antiepileptic drugs, but the pharmacological properties that distinguish them are poorly understood. We compared the interactions of representative agents from each class on their putative targets using well-characterized radioligand binding assays.
depression of excitatory neurotransmission and enhancement of inhibitory neurotransmission. Prolongation of inhibition by positive modulation of postsynaptic GABA A receptor function at GABAergic synapses is thought to be an important component of the depressant effects of volatile anaesthetics and multiple chemically distinct i.v. anaesthetics. Many general anaesthetics, the volatile agents in particular, depress excitatory glutamatergic transmission as well, most likely by presynaptic mechanisms involving inhibition of neurotransmitter release. 3±5 The mechanisms of action proposed for many antiepileptic drugs also involve modulation of excitatory and inhibitory synaptic transmission through effects on ion channels and neurotransmitter receptors. 2 These mechanisms include enhancement of inhibitory GABAergic transmission 6 and depression of glutamatergic excitatory transmission. 7 There is also overlap in the clinical effects of these drugs: many general anaesthetics possess anticonvulsant activity, 8 while many antiepileptic drugs have sedative effects. 6 Furthermore, the molecular targets implicated in producing these effects common to both drugs include GABA A receptors, Na + channels, Ca 2+ channels, and K + channels. Many members of the ligand-gated ion channel superfamily are sensitive to general anaesthetics. 9 The GABA A receptor is particularly sensitive: electrophysiological, biochemical, and pharmacological evidence suggests that potentiation of these receptors is important for the actions of many anaesthetics, and of the i.v. agents in particular. General anaesthetics also have effects on voltage-gated ion channels, which include inhibition of Ca 2+ channels, activation of K + channels, and inhibition of Na + channels. 10 Actions on GABA A receptors and voltage-gated ion channels also contribute to the therapeutic actions of most antiepileptic drugs. For example, GABA A receptors are potentiated by barbiturates, 6 and voltage-gated Na + channels 11 and Ca 2+ channels 12 are inhibited by therapeutic concentrations of many antiepileptic drugs. The molecular mechanisms that distinguish an anaesthetic from an antiepileptic drug are poorly understood. In an effort to assess the relative potencies of general anaesthetics and antiepileptic drugs on their putative central nervous system (CNS) targets, we undertook a comparative neurochemical analysis of their interactions with GABA A receptors, voltage-gated Na + and Ca 2+ channels and ATP-sensitive K + (K ATP ) channels using radioligand binding assays.
Methods

Materials
Experiments were performed in accordance with the National Institutes of Health guidelines for the care and use of laboratory animals as approved by the Weill Medical College of Cornell University Institutional Animal Care and Use Committee. 
Isolation of synaptosomes
Synaptosomes, a subcellular fraction that consists of pinched-off nerve terminals, retain a number of the functional properties of intact nerve endings, including ligand binding to Na + channels 13 and L-type Ca 2+ channels.
14 Presynaptic localization of K ATP + channels has been demonstrated by neurotransmitter release studies. 15 As GABA A receptors are predominantly postsynaptic and endogenous synaptosomal GABA inhibits [ 35 S]TBPS binding, 16 well-washed cortical membranes were used for analysis of [ 35 S]TBPS binding to GABA A receptors. Synaptosomes were prepared by the discontinuous Percoll density gradient method of Dunkley and colleagues 17 from cerebral cortex adult male Sprague±Dawley rats (150±200 g). The synaptosomal fraction was collected from the 23%/10% Percoll interface and diluted with ®ve volumes of assay buffer (as described below for each method). Synaptosomes were centrifuged at 23 000 g for 10 min and resuspended in the appropriate buffer to remove Percoll. Their protein concentration was determined by the method of Bradford 18 using bovine serum albumin as a standard.
Cortical membrane preparation
Rat cerebral cortex was homogenized in 50 volumes of 50 mM Tris±citrate buffer, pH 7.5, with a Brinkmann Polytron (Brinkmann Instruments, Westbury, NY, USA). The homogenate was centrifuged for 15 min at 20 000 g at 4°C, and the resulting pellets were resuspended in 50 volumes of 50 mM Tris±HCl buffer, pH 7.5. This centrifugation and resuspension was repeated ®ve times.
After the ®nal centrifugation, pellets were resuspended in the same buffer and stored at ±70°C for up to 1 week.
Equilibrium binding assays
Assays were performed under conditions optimal for each particular ligand both to facilitate comparisons of our data with published control values and to provide optimal conditions for each assay. , with or without test drugs, in a ®nal volume of 0.25 ml. Binding reactions were started by addition of synaptosomes (200 mg of protein) in 0.1 ml of assay buffer 1. After incubation at 37°C for 60 min, the reaction was terminated by addition of 3 ml of ice-cold wash buffer 1 (163 mM choline chloride, 5 mM HEPES±Tris, pH 7.4, 1.8 mM CaCl 2 , 0.8 mM MgCl 2 ). Synaptosomes were collected immediately on to Whatman GF/C glass ®bre ®lters (Whatman, Maidstone, UK) with a Brandel cell harvester (Brandel, Gaithersburg, MD, USA) and washed twice with 4 ml of wash buffer 1. Radioactivity on the ®lters was determined by liquid scintillation spectrometry in BioSafe NA scintillation cocktail (Research Products International, Mount Prospect, IL, USA). Non-speci®c binding (10±20% of total binding) was determined in the presence of 0.3 mM veratridine, which binds to the same site as BTX-B. 13 Reactions were terminated by rapid ®ltration with two 4 ml washes of cold assay buffer 3, and radioactivity was determined by liquid scintillation spectrometry as above. Non-speci®c binding (<5% of the total binding) was measured in the presence of 10 mM picrotoxin. 
Drug preparation
Efforts were made to analyse concentrations of drugs that inhibited radioligand binding to 20±80% of control; however, in some instances maximal drug concentration was limited by agent solubility. Stock solutions of propofol, Anaesthetic and antiepileptic drug targets thiopental, etomidate, alphaxalone, carbamazepine, phenytoin, phenobarbital, and CHEB were prepared in dimethyl sulphoxide, stored at ±20°C, and diluted in corresponding assay buffers on the day of experiment. Dimethyl sulphoxide at 0.05±1% (v/v) did not affect any of the measured variables (data not shown). Stock solutions of pentobarbital, ketamine, tetracaine, and lidocaine were made in the respective assay buffers. Volatile anaesthetics were tested both as diluted solutions in dimethyl sulphoxide and as saturated buffer solutions, with similar effects. Assays with volatile anaesthetics were performed in capped tubes; aqueous concentrations in parallel assays were measured by gas chromatography. 24 Reported drug concentrations refer to total in the assay concentrations. These provide an upper limit of the free concentrations, which may be considerably lower for drugs with substantial protein/lipid binding.
Statistical analysis
Results are reported as mean (SD). Statistical differences between control and experimental values were determined by analysis of variance (ANOVA) with Fisher's post hoc test. Binding data were ®tted to a single-site sigmoidal concentration±effect curve 50 is the drug concentration at half maximal inhibition, and h is the slope or Hill coef®cient) by non-linear regression using GraphPad Prism v. 3.02 (GraphPad Software, San Diego, CA, USA).
Curves were ®t to E max =100% inhibition; goodness of ®t (R 2 ) was >0.90 for all curves except that for CHEB effects on [
3 H]BTX-B binding. Each experiment included two to three replicates for each data point and was performed three to ®ve times.
Results
The effects of selected anaesthetic and antiepileptic compounds are summarized in Table 1 , along with their clinically effective concentrations. Representative i.v. general anaesthetics, volatile general anaesthetics, antiepileptic drugs, and local anaesthetics were tested using a single tissue preparation under comparable assay conditions in order to minimize methodological differences in potency between studies due to tissue source, buffer composition, ligand concentration, etc. The pro®les for inhibition of radioligand binding to the four ion channels examined differed between the classes of drugs and between agents within each class. (Fig. 4 , Table 1 ). Inhibition correlated with their clinically effective concentrations in producing local anaesthesia. The Hill slopes for these agents were~1. 
General anaesthetics
receptors. Use of an intact preparation rather than heterologously expressed recombinant receptors ensures that native receptor subunit combinations are represented in physiological ratios together with endogenous auxillary subunits.
Limitations
Radioligand binding is a versatile, reproducible technique that is amenable to high volume comparative analysis of multiple drug effects, but it is subject to certain limitations. A major limitation of this technique is that drug effects on radioligand binding do not necessarily re¯ect effects on target function, although considerable evidence supports such a correlation for many targets. Another limitation, which applies to all studies of isolated drug targets, is that the degree of effect on an isolated target in vitro may not correlate with the magnitude of the effect in vivo. Thus, effects detected in vitro may be magni®ed or minimized in a physiological context.
Radioligand binding results are limited in that each radioligand is sensitive to direct or allosteric interactions with a single site on the target of interest, most of which are large multimeric proteins. For example, weak or absent effects observed using a radioligand speci®c for one site could lead to the erroneous conclusion that no interaction exists, when a potent effect may be observed with a second radioligand to another site (as occurs with the Na + channel 25 ). The speci®city of a radioligand for a single receptor subtype also limits the generalization of results to other related receptor subtypes. For example, weak effects on [
3 H]PN200-110 binding to L-type Ca 2+ channels do not exclude signi®cant effects on other Ca 2+ channel subtypes. This limitation is a particular problem for K + channels, for which few speci®c ligands are available. Our choice of a single species and brain region facilitated comparisons between drugs and with other studies, but could obscure important species, tissue or region-speci®c effects. Despite these limitations, this approach allows a useful comparison of anaesthetic and antiepileptic drugs on multiple targets in a single preparation under similar conditions.
Anaesthetic and antiepileptic drug targets
Therapeutic drug concentrations
The clinically relevant concentrations of the study drugs (EC 50 values for i.v. drugs; minimum alveolar concentration [MAC] for volatile anaesthetics) are used as benchmarks for evaluating the relevance of the observed IC 50 values to their therapeutic effects (Table 1) . Although a direct correlation between the two is not necessary, some overlap between the concentration±effect curve in vitro with the clinically effective concentrations should exist. For the i.v. drugs, accurate effect site concentrations are rarely available, but must be derived from blood concentrations obtained at pseudo-steady state after corrections for lipid and protein binding. The derivation of the EC 50 values for pentobarbital and thiopental has been described. 9 The value for propofol is taken as twice the EC 50 value for loss of the righting re¯ex in tadpoles. 26 
I.V. anaesthetics
Of the i.v. anaesthetics, the neurosteroid alphaxalone was highly selective for inhibition of [ 35 Table 2) . Some of the quantitative differences obtained with different preparations may result from variations in GABA A receptor subunit isoform composition. 27 In addition to potent effects on [ 35 S]TBPS binding to GABA A receptors, propofol may have signi®cant inhibitory actions on Na + channels. This is consistent with evidence for some GABA A receptor-independent effects of propofol on synaptic transmission in rat hippocampal slices. 28 The IC 50 channels was observed. This is consistent with the minimal myocardial depression produced by ketamine compared with other anaesthetics, for which signi®cant myocardial depression results in part from block of myocardial Ca 2+ channels. Ketamine inhibited veratridine-induced release of GABA with an IC 50 of 100 mM without signi®cantly affecting KCl-evoked release from rat brain synaptosomes, 34 further supporting greater antagonism of Na + channels than of Ca 2+ channels. Antagonism of N-methyl-D-aspartate (NMDA) receptors resulting in disruption of glutamatergic transmission is thought to underlie the dissociative anaesthetic action of ketamine, 35 although other actions such as blocking of neuronal nicotinic acetylcholine receptors may also be involved. The clinical pro®les of other i.v. anaesthetics differ qualitatively from the dissociative anaesthesia produced by ketamine, in keeping with their distinct pro®les for inhibition of radioligand binding inhibition.
A role for L-type voltage-gated Ca 2+ channels in general anaesthesia has been suggested by ®ndings that the L-type Ca 2+ channel antagonist nitrendipine increases the anaesthetic potencies of ethanol, pentobarbitone, and benzodiazepines in mice. 36 However, i. (Table 2 ), which they interpreted as consistent with small effects at clinical concentrations for all agents except ketamine. However, some of their IC 50 values were estimated by extrapolation from incomplete concentration±-effect curves, and may thus be underestimates. Other studies also support the conclusion that dihyropyridine binding to brain L-type Ca 2+ channels is relatively insensitive to i.v. anaesthetics ( Table 2 ). Binding of [ 3 H]verapamil, a phenylalkylamine which binds to the L-type Ca 2+ channel a 1 subunit at a site distinct from that of the dihydropyridines, was also insensitive to various i.v. anaesthetics. 38 Collectively, these ®ndings support our conclusion that Ltype Ca 2+ channels do not play a major role in the anaesthetic actions of i.v. anaesthetics.
Volatile anaesthetics
The volatile anaesthetic agents tested had signi®cant effects on both This supports the hypothesis that these agents act through combined actions on both Na + channels and GABA A receptors. Inhibition of CNS Na + channels by volatile anaesthetics at clinical concentrations has also been demonstrated electrophysiologically 39 and biochemically. 24 Volatile anaesthetics reversibly inhibit peak current and induce a hyperpolarizing shift in the voltage dependence of steady-state inactivation of rat neuronal Na + channels stably expressed in Chinese hamster ovary cells 39 or in isolated dorsal root ganglion neurons. 40 Volatile anaesthetics also inhibit veratridine-evoked glutamate release from isolated nerve terminals (halothane IC 50 =670 mM) with greater potency than release evoked by elevated KCl (no effect at 650 mM). 3 24 This pattern of inhibition is consistent with greater sensitivity of presynaptic Na + channels to inhibition by volatile anaesthetics than of the Ca 2+ channels coupled to glutamate release. Volatile anaesthetic action at presynaptic Na + channels is further supported by our ®ndings that halothane inhibits veratridine-evoked 22 42 These assays are apparently markedly dependent on conditions such as radioligand concentration, membrane preparation, species, and/or incubation conditions. We employed isolated rat cerebrocortical nerve terminals, while others employed rat forebrain membranes 21 or mouse cerebrocortical membranes. This suggests the possibility that nerve terminal L-type Ca 2+ channels may be less sensitive to volatile anaesthetics than somatodendritic channels (the principal subcellular location of neuronal L-type Ca 2+ channels 43 ). This is supported by the observation that glutamate release from rat cerebrocortical synaptosomes evoked by elevated KCl (which activates voltage-gated Ca 2+ channels) is insensitive to L-type Ca 2+ channel antagonists or to volatile anaesthetics at clinical concentrations. 3 In contrast, electrophysiological experiments indicate inhibition of somatic Ca 2+ channels at clinical concentrations of halothane and iso¯urane in cultured hippocampal pyramidal neurons (T-, L-, N-and P-type channels), 44 isolated dorsal root ganglion neurons (T-, L-, and N-type channels) 45±47 and isolated recombinant Ca 2+ channels expressed in Xenopus oocytes. 48 The involvement of volatile anaesthetic inhibition of voltage-gated Ca 2+ channels, and of L-type channels in particular, in the production of the anaesthetic state remains unclear, 10 but appears unlikely from the present data.
Antiepileptic drugs
The mechanisms of action of currently used antiepileptic drugs 2 (Table 2) . 50 We have reported previously the selectivity of phenytoin (IC 50 =220 mM), carbamazepine (IC 50 =200 mM), lamotrigine (IC 50 =200 mM), and riluzole (IC 50 =4.8 mM) for block of presynaptic Na + channeldependent vs Ca 2+ channel-dependent release of glutamate. 51 52 It is unclear why these results differ so much from ours given that this ligand is thought to bind to the same site as [
3 H]PN200-110. The high potency of phenytoin in particular is inconsistent with previous studies indicating the greater relative potency of this agent at voltage-gated Na + channels compared to Ca 2+ channels. 2 51 Local anaesthetics
Inhibition of voltage-gated Na + channels and disruption of axonal conduction is the basis of the analgesic actions of local anaesthetics. 53 Lidocaine and tetracaine were highly selective for inhibition of [ 3 H]BTX-B binding in isolated rat cerebrocortical nerve terminals (Table 2) . Clinically achieved concentrations of local anaesthetics are unlikely to have signi®cant actions at the other channels tested. Both drugs tested were more effective at Na + channels than at Ltype Ca 2+ channels by approximately 100-fold ( 
